There have been changes to Medicare coverage for diabetic products, specifically related to the Medicare Part D prescription drug plans. In 2021, a new insulin benefit program was introduced that caps the cost of insulin at $35 per month per prescription for eligible beneficiaries. This program is available for those enrolled in a Medicare Part D prescription drug plan and who use certain types of insulin.
Additionally, Medicare covers certain types of diabetic supplies, including blood glucose monitors, test strips, lancets, and other necessary accessories. However, the specific products that are covered and the amount of coverage may vary depending on the beneficiary’s plan.
It’s important for beneficiaries to review their plan’s coverage for diabetic products and services to ensure that they are receiving the appropriate coverage and that they are not paying more than necessary. Beneficiaries can contact their plan or Medicare directly for more information about coverage for diabetic products.